You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Medtronic
Merck
Express Scripts
Mallinckrodt

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

Testosterone propionate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for testosterone propionate and what is the scope of patent protection?

Testosterone propionate is the generic ingredient in one branded drug marketed by Bel Mar, Elkins Sinn, Lilly, and Watson Labs, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-nine drug master file entries for testosterone propionate.

Summary for testosterone propionate
US Patents:0
Tradenames:1
Applicants:4
NDAs:8
Drug Master File Entries: 69
Bulk Api Vendors: 63
Patent Applications: 5,230
DailyMed Link:testosterone propionate at DailyMed

US Patents and Regulatory Information for testosterone propionate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs TESTOSTERONE PROPIONATE testosterone propionate INJECTABLE;INJECTION 085490-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs TESTOSTERONE PROPIONATE testosterone propionate INJECTABLE;INJECTION 080188-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Elkins Sinn TESTOSTERONE PROPIONATE testosterone propionate INJECTABLE;INJECTION 080276-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bel Mar TESTOSTERONE PROPIONATE testosterone propionate INJECTABLE;INJECTION 080742-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs TESTOSTERONE PROPIONATE testosterone propionate INJECTABLE;INJECTION 083595-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Johnson and Johnson
Moodys
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.